Company / Named in our posts
Peak Bio.
Follow Peak BioPeak Bio includes pH Pharma Co., Ltd. (now Peak Bio Co., Ltd.), certain wholly-owned subsidiaries, and certain allocated assets and liabilities, including PHP-303 and PH-1 ADC.[1]
01Deal
Deals on Carrywatch
Every deal that names Peak Bio, and its role in each.
Ignyte / Peak Bio
Ignyte and Peak Bio complete a business combination
See deal detailsDeal Web
Peak Bio and 1 firm it shares a posted deal with, and the path to any other firm.
Financials
3 fiscal years of figures as Peak Bio reported them.
News
Loading headlines.
Sources
As of 24 Oct 2026.
- 01Exhibit 99.1 — Peak Bio carve-out condensed consolidated financial statements
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
- 02SEC EDGAR company record for Peak Bio, Inc.
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
Deal posts naming Peak Bio:
- P01Peak Bio, Inc.: Ignyte / Peak Bio
7 Nov 2022